Related Experiment Videos
Pergolide improvement in neuroleptic-resistant Tourette cases: various mechanisms causing tics
C Cianchetti1, A Fratta, T Pisano
1Child and Adolescent Neuropsychiatric Clinic, University of Cagliari, Via Ospedale 119, I-09124 Cagliari, Italy. cianchet@unica.it
Summary
This study suggests Tourette's disorder (TD) may involve different brain pathways in patients. Some children with TD responded to pergolide but not typical neuroleptics, indicating varied treatment responses.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Tourette's disorder (TD) is a neurological condition characterized by involuntary movements and vocalizations called tics.
- Current treatments often target dopamine pathways, primarily through D2 receptor blockers, with variable success rates.
Observation:
- Three children with TD did not improve with standard neuroleptic medications (D2 blockers).
- These same children experienced significant and lasting tic reduction with pergolide treatment.
- One patient presented with unusual tic symptoms, including violent myoclonias.
Findings:
- The positive response to pergolide, despite non-response to D2 blockers, suggests a non-D2 receptor-mediated mechanism in these cases.
- Pergolide's efficacy may involve pre-synaptic inhibition of dopamine release via D1 receptors on GABAergic neurons.
- This contrasts with the typical assumption of D2-receptor-carrying GABAergic neuron involvement.
Implications:
- The findings suggest that distinct neurobiological pathways may underlie Tourette's disorder in different individuals.
- This highlights the potential for personalized treatment strategies based on individual patient neurobiology.
- Further research into these differential pathways could lead to more effective therapeutic interventions for TD.